🇺🇸 FDA
Patent

US 7399606

Methods for identifying IκB Kinase (IKK) inhibitors

granted A61KA61K31/00A61K31/557

Quick answer

US patent 7399606 (Methods for identifying IκB Kinase (IKK) inhibitors) held by The Regents of the University of California expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/00, A61K31/557, A61K31/5575